SCHEMBL30037232

SCHEMBL30037232

Nc1cccc(C(=O)O)c1C(=O)c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
GAA P10253 2/20 0.54
APP P05067 1/20 0.54
HCAR3 P49019 1/20 0.54
HCAR2 Q8TDS4 1/20 0.54
F7 P08709 1/20 0.49
F3 P13726 1/20 0.49
SARM1 Q6SZW1 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.49
SIRT6 Q8N6T7 1/20 0.49
SIRT1 Q96EB6 1/20 0.49
SIRT3 Q9NTG7 1/20 0.49
SIRT5 Q9NXA8 1/20 0.49
SIRT4 Q9Y6E7 1/20 0.49
HDAC1 Q13547 3/20 0.48
HDAC3 O15379 2/20 0.48
HDAC2 Q92769 2/20 0.48
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22769978 0.84 ALDH1A1 (0.58) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL8819155 0.83 ALDH1A1 (0.56) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL30038107 0.83 MEN1 (0.52) ALDH1A1GAAMAPTKDM4EMEN1
SCHEMBL6917724 0.82 MAPT (0.66) ALDH1A1GAAMAPTTDP1L3MBTL1
SCHEMBL6950942 0.81 GAA (0.65) ALDH1A1GAAAPPHCAR3HCAR2
Water SCHEMBL27513562 0.80 GAA (0.62) ALDH1A1GAAAPPHCAR3HCAR2
SCHEMBL7289960 0.79 AKR1C3 (0.66) ALDH1A1GAAAPPHCAR3HCAR2
Sulfuric Acid SCHEMBL28864660 0.76 GAA (0.57) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL23780926 0.74 ALDH1A1 (0.95) ALDH1A1GAAAPPHCAR3HCAR2
Niacin SCHEMBL1899332 0.74 ALDH1A1 (0.95) ALDH1A1GAAAPPHCAR3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230355550-A1 KETAMINE COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2023-11-09 US disclosed
US-11753378-B2 Ketamine compounds and processes for making and using them ZEVRA THERAPEUTICS, INC. (US) 2023-09-12 US disclosed
US-20220348544-A1 KETAMINE COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM ALTER DOMUS (US) LLC 2022-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753378-B2 Ketamine compounds and processes for making and using them OPRK1, GRIK3, GRIN3B ALDH1A1 3239/4885GAA 2960/4885APP 1345/4885
US-20230355550-A1 KETAMINE COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM OPRK1, GRIK3, GRIN3B ALDH1A1 3239/4885GAA 2960/4885APP 1345/4885
US-20220348544-A1 KETAMINE COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM OPRK1, GRIK3, GRIN3B ALDH1A1 3239/4885GAA 2960/4885APP 1345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.